• Jun H Lee, Kevin K Chang, Changhwan Yoon, Laura H Tang, Vivian E Strong, and Sam S Yoon.
• Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.
• Ann. Surg. 2018 Jan 1; 267 (1): 105-113.

ObjectiveTo examine sites of initial recurrence in patients after resection of gastric and gastroesophageal junction Siewert II/III adenocarcinoma (GA).BackgroundThere are few recent studies on recurrence for Western patients following potentially curative resection of GA.MethodsA review of a prospectively maintained, single institution database was performed. Clinicopathologic factors, site(s) of initial recurrence, disease-free survival, and overall survival were examined.ResultsFrom January 2000 to June 2010, 957 patients underwent potentially curative resection for GA, 435 patients (46%) had recurrent disease, and complete data on recurrence site(s) could be obtained in 386 patients. Tumors were Lauren intestinal type in 206 (53%) and diffuse or mixed-type in 180 (47%). Median time to recurrence was 12 months and 75% of recurrences occurred within 2 years. There was a significant difference in pattern of initial recurrence between the intestinal and diffuse/mixed cohorts (P < 0.001). For intestinal tumors, distant metastasis was the most common site (54%), followed by locoregional (20%), peritoneal (15%), and multifocal (11%). For diffuse/mixed tumors, peritoneal recurrence was the most common (37%), followed by distant (32%), locoregional (22%), and multifocal (9%). On multivariate analysis, Lauren histologic type was the only significant factor that was associated with both peritoneal recurrence (diffuse, hazard ratio 2.22, confidence interval 1.38-3.94) and distant recurrence (intestinal, hazard ratio 1.888, confidence interval 1.202-2.966). After recurrence, median overall survival was only 8.4 months.ConclusionsIn GA patients who recur after resection, patterns of recurrence vary significantly based on Lauren histologic type.

29 keywords...

hide…